128 related articles for article (PubMed ID: 32839078)
21. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
[TBL] [Abstract][Full Text] [Related]
22. Risk-Adapted Adjuvant Chemotherapy After Concomitant Fluoropyrimidine-Radiotherapy Neoadjuvant Treatment for Patients With Resectable CT3-4 or N+ Rectal Cancer: Five-Year Disease-Free Survival Results of a Single-Center Series.
Sastre J; Serrano JJ; Fernández C; Ramirez C; Ortega L; García-Paredes B; Corona J; Alfonso R; Córdoba S; Díaz-Rubio E
Clin Colorectal Cancer; 2016 Jun; 15(2):128-34. PubMed ID: 26385572
[TBL] [Abstract][Full Text] [Related]
23. Effect of increasing radiation dose on pathologic complete response in rectal cancer patients treated with neoadjuvant chemoradiation therapy.
Hall MD; Schultheiss TE; Smith DD; Fakih MG; Wong JY; Chen YJ
Acta Oncol; 2016 Dec; 55(12):1392-1399. PubMed ID: 27762654
[TBL] [Abstract][Full Text] [Related]
24. Why is neoadjuvant chemoradiation therapy underused for locally advanced rectal cancer?
Molinari C; Passardi A
Expert Rev Gastroenterol Hepatol; 2016 Dec; 10(12):1317-1319. PubMed ID: 27754713
[No Abstract] [Full Text] [Related]
25. Management of Locoregional Rectal Cancer.
Willett CG
J Natl Compr Canc Netw; 2018 May; 16(5S):617-619. PubMed ID: 29784739
[TBL] [Abstract][Full Text] [Related]
26. Feasibility of relatively low neoadjuvant radiation doses for locally advanced rectal cancer: A propensity score-matched analysis.
Ye W; Shi L; Qian L; Sun Y; Sun X
Cancer Rep (Hoboken); 2019 Oct; 2(5):e1188. PubMed ID: 32721108
[TBL] [Abstract][Full Text] [Related]
27. Rectal Cancer in 2018: A Primer for the Gastroenterologist.
Goldenberg BA; Holliday EB; Helewa RM; Singh H
Am J Gastroenterol; 2018 Dec; 113(12):1763-1771. PubMed ID: 30008472
[No Abstract] [Full Text] [Related]
28. Prognostic impact of residual lateral lymph node metastasis after neoadjuvant (chemo)radiotherapy in patients with advanced low rectal cancer.
Akiyoshi T; Toda S; Tominaga T; Oba K; Tomizawa K; Hanaoka Y; Nagasaki T; Konishi T; Matoba S; Fukunaga Y; Ueno M; Kuroyanagi H
BJS Open; 2019 Dec; 3(6):822-829. PubMed ID: 31832589
[TBL] [Abstract][Full Text] [Related]
29. The Financial Impact of Fractionation Scheme and Treatment Planning Method for Rectal Cancer in the United States.
Moore A; Den RB; Gordon N; Sarfaty M; Kundel Y; Brenner B; Goldstein DA
Clin Colorectal Cancer; 2019 Sep; 18(3):209-217. PubMed ID: 31255477
[TBL] [Abstract][Full Text] [Related]
30. Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Recent Advances and Ongoing Challenges.
Body A; Prenen H; Lam M; Davies A; Tipping-Smith S; Lum C; Liow E; Segelov E
Clin Colorectal Cancer; 2021 Mar; 20(1):29-41. PubMed ID: 33531256
[TBL] [Abstract][Full Text] [Related]
31. Neoadjuvant chemoradiation in locally advanced rectal cancer: the surgeon's perspective.
Azin A; Khorasani M; Quereshy FA
J Clin Pathol; 2019 Feb; 72(2):133-134. PubMed ID: 30670565
[No Abstract] [Full Text] [Related]
32. Gender differences in stage at diagnosis and preoperative radiotherapy in patients with rectal cancer.
Sarasqueta C; Zunzunegui MV; Enríquez Navascues JM; Querejeta A; Placer C; Perales A; Gonzalez N; Aguirre U; Baré M; Escobar A; Quintana JM;
BMC Cancer; 2020 Aug; 20(1):759. PubMed ID: 32795358
[TBL] [Abstract][Full Text] [Related]
33. Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
Benson AB; Venook AP; Al-Hawary MM; Cederquist L; Chen YJ; Ciombor KK; Cohen S; Cooper HS; Deming D; Engstrom PF; Grem JL; Grothey A; Hochster HS; Hoffe S; Hunt S; Kamel A; Kirilcuk N; Krishnamurthi S; Messersmith WA; Meyerhardt J; Mulcahy MF; Murphy JD; Nurkin S; Saltz L; Sharma S; Shibata D; Skibber JM; Sofocleous CT; Stoffel EM; Stotsky-Himelfarb E; Willett CG; Wuthrick E; Gregory KM; Gurski L; Freedman-Cass DA
J Natl Compr Canc Netw; 2018 Jul; 16(7):874-901. PubMed ID: 30006429
[TBL] [Abstract][Full Text] [Related]
34. Rectal cancer: Watch-and-wait and continuing the rectal-preserving strategy with local excision for incomplete response or limited regrowth.
Al-Najami I; Jones HJ; Dickson EA; Muirhead R; Deding U; James DR; Cunningham C
Surg Oncol; 2021 Jun; 37():101574. PubMed ID: 33853031
[TBL] [Abstract][Full Text] [Related]
35. High Expression of VSTM2L Induced Resistance to Chemoradiotherapy in Rectal Cancer through Downstream IL-4 Signaling.
Liu H; Zhang Z; Zhen P; Zhou M
J Immunol Res; 2021; 2021():6657012. PubMed ID: 33506057
[TBL] [Abstract][Full Text] [Related]
36. Rectal NETs and rectosigmoid junction NETs may need to be treated differently.
Cai W; Ge W; Hu H; Mao J
Cancer Med; 2020 Feb; 9(3):971-979. PubMed ID: 31840409
[TBL] [Abstract][Full Text] [Related]
37. Risk Stratification Using Neoadjuvant Rectal Score in the Era of Neoadjuvant Chemoradiotherapy: Validation With Long-term Outcome Data.
Lim YJ; Song C; Jeon SH; Kim K; Chie EK
Dis Colon Rectum; 2021 Jan; 64(1):60-70. PubMed ID: 33306532
[TBL] [Abstract][Full Text] [Related]
38. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.
Bosset JF; Calais G; Mineur L; Maingon P; Stojanovic-Rundic S; Bensadoun RJ; Bardet E; Beny A; Ollier JC; Bolla M; Marchal D; Van Laethem JL; Klein V; Giralt J; Clavère P; Glanzmann C; Cellier P; Collette L;
Lancet Oncol; 2014 Feb; 15(2):184-90. PubMed ID: 24440473
[TBL] [Abstract][Full Text] [Related]
39. Limited Role for Routine Restaging After Neoadjuvant Therapy in Locally Advanced Rectal Cancer.
Caturegli I; Molin MD; Laird C; Molitoris JK; Bafford AC
J Surg Res; 2020 Dec; 256():317-327. PubMed ID: 32712447
[TBL] [Abstract][Full Text] [Related]
40. The Impact of Chemotherapy Completion on the Efficacy of Irinotecan in the Preoperative Chemoradiotherapy of Locally Advanced Rectal Cancer: An Expanded Analysis of the CinClare Phase III Trial.
Wang J; Fan J; Li C; Yang L; Wan J; Zhang H; Zhang Z; Zhu J
Clin Colorectal Cancer; 2020 Jun; 19(2):e58-e69. PubMed ID: 32265117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
